DGX

QUEST DIAGNOSTICS INC

SEC CIK 1022079
$195.00 −4.6% · 90 days
90-day buys
$0
0 open-market
90-day sells
$3.57M
2 open-market
Net insider flow
−$3.57M
Net selling
Filings shown
183
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at DGX have sold a net $3.57M of stock (0 open-market buys vs 2 sells).

Largest recent trade: Rusckowski Stephen H sold $35.04M of DGX, trimming their stake 55%.

Most active filer: Doherty Catherine T., with 44 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for DGX, newest first
View on SEC EDGAR ↗
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 28, 2020 ΔOwn −1.7%

Prevoznik Michael E sold $75.2K of DGX, trimming their stake 2%.

−$75.2K
690 sh @ $109
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Feb 28, 2020 ΔOwn −1.1%

Doherty Catherine T. sold $86K of DGX, trimming their stake 1%.

−$86K
789 sh @ $109
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Feb 28, 2020 ΔOwn −2.8%

Davis J. E. sold $119.9K of DGX, trimming their stake 3%.

−$119.9K
1,100 sh @ $109
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 28, 2020 ΔOwn −0.8%

Prevoznik Michael E sold $35.7K of DGX, trimming their stake 1%.

−$35.7K
321 sh @ $111
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Feb 28, 2020 ΔOwn −0.5%

Doherty Catherine T. sold $40.9K of DGX, trimming their stake 1%.

−$40.9K
368 sh @ $111
Advertisement
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Feb 28, 2020 ΔOwn −1.2%

Davis J. E. sold $56.7K of DGX, trimming their stake 1%.

−$56.7K
510 sh @ $111
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Feb 26, 2020 ΔOwn −1.4%

Davis J. E. sold $67.4K of DGX, trimming their stake 1%.

−$67.4K
598 sh @ $113
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Feb 26, 2020 ΔOwn −0.6%

Doherty Catherine T. sold $45.7K of DGX, trimming their stake 1%.

−$45.7K
405 sh @ $113
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Jan 3, 2020 ΔOwn −32%

Davis J. E. sold $6.14M of DGX, trimming their stake 32%.

−$6.14M
58,258 sh @ $105
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Jan 3, 2020 ΔOwn −6.1%

Davis J. E. sold $790.6K of DGX, trimming their stake 6%.

−$790.6K
7,423 sh @ $107
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Jan 3, 2020 ΔOwn −60%

Davis J. E. sold $7.28M of DGX, trimming their stake 60%.

−$7.28M
69,003 sh @ $105
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Jan 3, 2020 ΔOwn −20%

Davis J. E. sold $942.9K of DGX, trimming their stake 20%.

−$942.9K
8,853 sh @ $107
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Dec 4, 2019 ΔOwn −14%

Prevoznik Michael E sold $1.27M of DGX, trimming their stake 14%.

−$1.27M
11,863 sh @ $107
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Dec 4, 2019 ΔOwn −45%

Prevoznik Michael E sold $3.46M of DGX, trimming their stake 45%.

−$3.46M
32,193 sh @ $108
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Dec 4, 2019 ΔOwn −1.3%

Prevoznik Michael E sold $53.9K of DGX, trimming their stake 1%.

−$53.9K
500 sh @ $108
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, President and CEO · Open-market sale · filed Jun 17, 2019 ΔOwn −53%

Rusckowski Stephen H sold $24.46M of DGX, trimming their stake 53%.

−$24.46M
244,565 sh @ $100
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Apr 26, 2019 ΔOwn −57%

Davis J. E. sold $4.52M of DGX, trimming their stake 57%.

−$4.52M
47,574 sh @ $95
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Apr 10, 2019 ΔOwn −13%

Davis J. E. sold $531.9K of DGX, trimming their stake 13%.

−$531.9K
5,900 sh @ $90
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Apr 10, 2019 ΔOwn −5.4%

Davis J. E. sold $190.5K of DGX, trimming their stake 5%.

−$190.5K
2,100 sh @ $91
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Apr 8, 2019 ΔOwn −45%

Doherty Catherine T. sold $5.48M of DGX, trimming their stake 45%.

−$5.48M
60,492 sh @ $91
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Apr 8, 2019 ΔOwn −8.0%

Doherty Catherine T. sold $533.6K of DGX, trimming their stake 8%.

−$533.6K
5,890 sh @ $91
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Mar 5, 2019 ΔOwn −7.9%

Prevoznik Michael E sold $292.8K of DGX, trimming their stake 8%.

−$292.8K
3,373 sh @ $87
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 28, 2019 ΔOwn −2.6%

Prevoznik Michael E sold $90.7K of DGX, trimming their stake 3%.

−$90.7K
1,048 sh @ $87
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 28, 2019 ΔOwn −0.9%

Prevoznik Michael E sold $31.7K of DGX, trimming their stake 1%.

−$31.7K
364 sh @ $87
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 27, 2019 ΔOwn −0.8%

Prevoznik Michael E sold $29.6K of DGX, trimming their stake 1%.

−$29.6K
336 sh @ $88
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, President and CEO · Open-market sale · filed May 29, 2018 ΔOwn −47%

Rusckowski Stephen H sold $18.03M of DGX, trimming their stake 47%.

−$18.03M
168,490 sh @ $107
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 6, 2018 ΔOwn −12%

Davis J. E. sold $517.3K of DGX, trimming their stake 12%.

−$517.3K
5,122 sh @ $101
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Mar 6, 2018 ΔOwn −7.6%

Doherty Catherine T. sold $561.2K of DGX, trimming their stake 8%.

−$561.2K
5,556 sh @ $101
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Mar 1, 2018 ΔOwn −0.8%

Doherty Catherine T. sold $60.1K of DGX, trimming their stake 1%.

−$60.1K
572 sh @ $105
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 1, 2018 ΔOwn −1.7%

Davis J. E. sold $68K of DGX, trimming their stake 2%.

−$68K
648 sh @ $105
Advertisement

About DGX insider activity

This page tracks every recent Form 4 filed for QUEST DIAGNOSTICS INC with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is DGX insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for QUEST DIAGNOSTICS INC usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.